Receive Our Newsletter

Genentech Provides Statement Regarding Patient Access to Hemlibra

industry_news_banner

Genentech has published a statement regarding patient access to Hemlibra (Emicizumab-kkwh). Read the full statement in its entirety here.

 

Comments (No comments)

Assisting and Advocating for the Bleeding Disorders Community